Lifeward Ltd. and CorLife, LLC have finalized a strategic partnership that designates CorLife as the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with workers' compensation claims. The agreement, announced on March 6, 2025, aims to expand access to this advanced mobility technology for workers who have sustained spinal cord injuries on the job.
The ReWalk Personal Exoskeleton is a lower-body exoskeleton system that enables individuals with spinal cord injuries (SCI) to stand and walk in everyday settings. It is currently the only personal exoskeleton on the market that offers users the ability to navigate stairs and curbs, making it particularly valuable for real-world use in home and community environments.
Strategic Benefits of the Partnership
This collaboration leverages CorLife's extensive network of credentialed providers and experts to incorporate the ReWalk Personal Exoskeleton into their comprehensive suite of services for injured workers. Additionally, CorLife's reimbursement team will manage all workers' compensation claims submissions for the device, streamlining the approval process.
Larry Jasinski, CEO of Lifeward, emphasized the significance of the partnership: "We are thrilled to expand our capabilities to better serve the needs of injured workers with SCI. Partnering with CorLife allows us to significantly increase awareness of the benefits of the ReWalk Personal Exoskeleton among individuals with workers' compensation and utilize CorLife's established expertise to facilitate efficient processing of claims."
The agreement is expected to help Lifeward achieve greater growth and market penetration in the workers' compensation sector, a critical avenue for expanding access to their innovative mobility solutions.
Addressing Critical Needs for Injured Workers
For individuals with spinal cord injuries sustained in workplace accidents, access to advanced mobility technology can be transformative. The ReWalk Exoskeleton serves as an essential tool for maintaining health and wellness after SCI, potentially reducing secondary complications associated with prolonged immobility.
Brad Sewell, Executive Director of CorLife, highlighted the company's commitment to providing comprehensive care: "As a leader in the workers' compensation industry, CorLife is dedicated to providing comprehensive care for injured workers, including mobility equipment, medical supplies, and home health care. Through this partnership, we aim to provide access to the ReWalk Personal Exoskeleton, empowering individuals to experience the health benefits and enhanced mobility that this groundbreaking technology offers."
About the Companies
Lifeward designs, develops, and commercializes rehabilitation solutions spanning the continuum of care in physical rehabilitation and recovery. Their portfolio includes innovative products such as the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, the company operates in the United States, Israel, and Germany.
CorLife, a division of Numotion, specializes in personalized ancillary benefits for workers' compensation carriers, third-party administrators, self-insured businesses, and injured workers nationwide. The company maintains an extensive network of credentialed clinical providers and experts, offering services including durable medical equipment, medical supplies, home access modifications, wheelchair-accessible vehicles, and home healthcare.
Clinical and Functional Significance
Spinal cord injuries represent some of the most challenging workplace injuries, often resulting in permanent disability and significant lifestyle adjustments. Traditional mobility options for individuals with SCI have been limited to wheelchairs, which, while practical, do not provide the physiological benefits of standing and walking.
The ReWalk Personal Exoskeleton addresses this gap by enabling users to stand upright and walk, potentially improving cardiovascular health, bone density, and psychological well-being. For workers injured on the job, this technology offers not just improved mobility but also the possibility of greater independence and quality of life.
Market Impact and Future Outlook
This partnership represents a significant development in the specialized field of exoskeleton technology for rehabilitation. By focusing specifically on the workers' compensation market, Lifeward and CorLife are addressing an important segment of patients who may benefit from advanced mobility solutions but often face challenges navigating the complex reimbursement landscape.
The collaboration between these two companies highlights the growing recognition of exoskeleton technology as a legitimate medical intervention rather than an experimental approach. As adoption increases and outcomes data accumulates, such partnerships may help establish new standards of care for individuals with workplace-related spinal cord injuries.
